Skip to content Skip to sidebar Skip to footer

Masterstroke in Pandemic Preparedness: CDC Partners with Cepheid to Fast-track Rapid Diagnostic Development

In a significant step to strengthen the United States' response to lethal outbreaks, the Centers for Disease Control and Prevention (CDC) has recently chosen Cepheid as a national collaborator. This partnership, part of a new federal initiative, seeks to hasten the progression and implementation of instant diagnostic testing during severe public health emergencies. This award,…

Read more

Building a Robust Future for Infection Control and Antimicrobial Resistance: Insights from the COVID-19 Pandemic

When the COVID-19 pandemic struck in 2020, its immense magnitude forced healthcare organizations worldwide into an immediate response mode. Despite the significant progress since, a not-so-obvious crisis is increasingly posing a global threat - antimicrobial resistance (AMR). The world’s response to AMR, in contrast to the highly responsive approach to COVID-19, offers a timely occasion…

Read more

Urgent Appeal for Accelerated Influenza A Subtyping amidst Rising Flu Rates – Guiding Healthcare Workers through the Response

In the midst of ongoing sporadic H5N1 avian flu occurrences and high volumes of seasonal flu, US Centers for Disease Control and Prevention (CDC) recommended swift subtyping of all influenza A cases in hospitalized patients, spotlighting the attention mainly on those in the Intensive Care Unit (ICU). The CDC communicated this through a Health Alert Network…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]